메뉴 건너뛰기




Volumn 27, Issue 36, 2009, Pages

Clinical utility of serum human epidermal growth factor receptor 2 extracellular domain levels: Stop the shilly-shally-it is time for a well-designed, large-scale prospective study

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB; TUMOR MARKER; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

EID: 74949097805     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.5100     Document Type: Letter
Times cited : (9)

References (4)
  • 1
    • 63349108087 scopus 로고    scopus 로고
    • Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients
    • Leary AF, Hanna WM, Van de Vijver MJ, et al: Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients. J Clin Oncol 10:1694-1705, 2009
    • (2009) J Clin Oncol , vol.10 , pp. 1694-1705
    • Leary, A.F.1    Hanna, W.M.2    Van de Vijver, M.J.3
  • 2
    • 63749132329 scopus 로고    scopus 로고
    • Utility of serum HER2 extracellular domain assessment in clinical decision making: Pooled analysis of four trials of trastuzumab in metastatic breast cancer
    • Lennon S, Barton C, Banken L, et al: Utility of serum HER2 extracellular domain assessment in clinical decision making: Pooled analysis of four trials of trastuzumab in metastatic breast cancer. J Clin Oncol 10:1685-1693, 2009
    • (2009) J Clin Oncol , vol.10 , pp. 1685-1693
    • Lennon, S.1    Barton, C.2    Banken, L.3
  • 3
    • 53149107465 scopus 로고    scopus 로고
    • Serum human epidermal growth factor receptor 2 proto-oncogene and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer
    • Ali SM, Carney WP, Esteva FJ, et al: Serum human epidermal growth factor receptor 2 proto-oncogene and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer. Cancer 113:1294-1301, 2008
    • (2008) Cancer , vol.113 , pp. 1294-1301
    • Ali, S.M.1    Carney, W.P.2    Esteva, F.J.3
  • 4
    • 23844534811 scopus 로고    scopus 로고
    • Reporting recommendations for tumor marker prognostic studies (REMARK)
    • McShane LM, Altman DG, Sauerbrei W, et al: Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97:1180-1184, 2005
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1180-1184
    • McShane, L.M.1    Altman, D.G.2    Sauerbrei, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.